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An abdominal aortic aneurysm (AAA) is a permanent, localized dilatation of the abdominal aorta. In western countries, the 
morbidity of AAA is approximately 8%. Currently, pharmacotherapies for AAA are limited. Here, we demonstrate that bai-
calein (BAI), the main component of the Chinese traditional drug “Huang Qin”, attenuates the incidence and severity of AAA 
in Apoe/ mice infused with angiotensin II (AngII). Mechanically, BAI treatment decreases AngII-induced reactive oxygen 
species (ROS) production in the aortic wall. Moreover, BAI inhibits inflammatory cell accumulation in the aortas of mice in-
fused with AngII. It also inhibits AngII-induced activation of matrix metalloproteinase 2 (MMP-2) and MMP-9 to maintain 
elastin content in vivo. In addition, it blocks AngII cascade by downregulating angiotensin type 1 receptor (AT1R) and inhibit-
ing mitogen-activated protein kinases (MAPKs). Taken together, our findings show that BAI is an effective agent for AAA 
prevention. 
baicalein, abdominal aortic aneurysm, oxidative stress, vascular inflammation, extracellular matrix degradation, AT1R, 
MAPKs 
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An abdominal aortic aneurysm (AAA) is defined as a per-
manent, localized dilatation of the abdominal aorta to 
1.5-fold more than the normal diameter. In western coun-
tries, the morbidity of AAA is approximately 8%. Owing to 
the lack of typical syndrome, the mortality rate associated 
with aortic rupture exceeds 80% (Nordon et al., 2011; 
Sakalihasan et al., 2005). Currently, AAA therapies mainly 
include pharmacotherapy and surgical approaches (open 
repair and endovascular aneurysm repair) (Brewster et al., 
2003). The chief function of pharmacotherapy, which con-
trols the risk factors, is to indirectly attenuate aneurysm 
development and aorta rupture by regulating blood pressure, 
serum lipid level, and blood coagulation (Bergoeing et al., 
2006; Miyake and Morishita, 2009). Therefore, developing 
new drugs that target the mechanism of AAA development 
is of great significance to AAA prevention and treatment. 
The involved pathophysiological processes mainly in-
clude oxidative stress, vascular inflammation, and extracel-
lular matrix degradation (Lopez-Candales et al., 1997; 
Thompson et al., 1997, 2002). Apoe/ mice infused with 
angiotensin II (AngII) is the most commonly employed 
animal model to study the pathogenesis of AAA since it 
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mimics almost all the clinical characteristics of human AAA 
(Daugherty and Cassis, 2004; Weiss et al., 2001). Notably, 
AngII cascade is upregulated in human AAA samples 
(Annambhotla et al., 2008; Golledge and Powell, 2007). 
Baicalein (BAI) , which is involved in oxidative stress, in-
flammation, tumorigenesis, and angiogenesisis, is the main 
component of the Chinese traditional drug “Huang Qin”, 
(Gao et al., 1999). It has been reported that BAI remarkably 
retards is chemia/reperfusion-induced myocardium injury 
(Liu et al., 2013; Wang et al., 2013). However, its exact 
mechanism remains elusive and its role in AAA develop-
ment has not been elucidated. 
In the present study, we examined the role of BAI in 
AAA induced by AngII treatment in Apoe/ mice. From the 
view of oxidative stress, vascular inflammation, and extra-
cellular matrix degradation, the relevant mechanisms were 
studied. The AngII cascade activation was also evaluated 
under BAI treatment. We believe that our findings may 
provide a new drug for AAA prevention and treatment. 
RESULTS  
BAI decreases AAA incidence in vivo 
BAI did not alter the gross morphology of the aortas in  
Apoe/ mice (Figure 1A). Consistent with previous findings 
(Satoh et al., 2009; Wang et al., 2012), the incidence of  
AAA in Apoe/ mice treated with vehicle after AngII infu-
sion for 4 weeks was 88% in our study. In contrast, only 
47% of BAI-treated Apoe/ mice developed AAA after 
AngII treatment (Figure 1B). No AAAs were detected in 
saline-infused mice.   
BAI attenuated AAA severity (the ratio of aorta weight 
to body weight and maximal abdominal aortic diameter) 
in vivo 
The maximal abdominal aortic diameter and the total aortic 
weight significantly increased after AngII infusion for 4 
weeks in all groups compared to that in saline-infused mice. 
Compared to AngII-infused mice treated with vehicle, the 
BAI-treated mice had decreased maximal abdominal aortic 
diameter and total aortic weight (Figure 2A–C). As shown 
in Tables 1 and 2, SBP, HR, and serum lipid levels did not 
differ between Apoe/ mice treated with BAI and those 
receiving vehicle after AngII infusion for 4 weeks.  
Taken together, BAI represses AngII-induced AAA in 
vivo, but it did not affect hemodynamic and lipid metabolic 
indices. 
BAI treatment attenuated AngII-induced ROS    
production in vivo 
Since oxidative stress is critical in AAA formation (Satoh et al., 




Figure 1 (color online)  Baicalein (BAI) treatment represses abdominal aortic aneurysms (AAA) formation in Apoe/ mice infused with angiotensin II 
(AngII). Mice were pre-treated with vehicle (Veh) or BAI (30 mg kg1 day1) via intraperitoneal injection for 1 week before infusion with saline or AngII for 
4 weeks. Treatment with vehicle or BAI (30 mg kg1 day1) via intraperitoneal injection was performed at the same time-point every day during the saline or 
AngII infusion. A, Representative photographs showing macroscopic features of aneurysms induced by AngII following treatment with vehicle or BAI. The 
arrows show typical AAAs (scale bars, 5 mm). B, The incidence of AngII-induced AAA in vehicle-treated Apoe/ mice (n=17) relative to BAI-treated Ap-
oe/ mice (n=17). AAAs were not detected in saline-infused mice (n=6 per group). *, P<0.05. 







(Baseline, beats min1) 
HR 
(AngII, beats min1) 
Veh Apoe/ 98.6±5.8 129.3±3.8* 553.8±13.6 524.6±16.0 
BAI Apoe/ 97.4±6.4 126.6±5.7* 538.3±18.6 535.7±22.4 
a) n=5 in baseline group; n=10 in AngII group; *, P<0.05 compared to baseline; data are mean±SE. 
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Table 2  Serum lipid levels in AngII-infused micea) 
Groups (AngII-infused) Cholesterol (mmol L1) Triglyceride (mmol L1) HDL-C (mmol L1) LDL-C (mmol L1) 
Veh Apoe/ 16.36±1.40 2.17±0.15 0.85±0.09 2.61±0.26 
BAI Apoe/ 15.73±0.98 2.43±0.41 0.91±0.04 2.71±0.27 
a) Results are expressed as mean±SE, n=10 in each group. 
 
Figure 2  Baicalein (BAI) treatment attenuates abdominal aorta dilatation in Apoe/ mice infused with angiotensin II (AngII). A and C, The ratio of the 
aorta weight to body weight (A) and maximal abdominal aortic diameter (C) in saline- and AngII-infused mice following treatment with vehicle or BAI (n=5 
in each group of Apoe/ mice infused with saline; n=14 for AngII-infused Apoe/ mice following treatment with vehicle; n=15 for AngII-infused Apoe/ 
mice following treatment with BAI). B, Representative H&E staining of suprarenal aortas from saline- and AngII-infused mice treated with vehicle or BAI. 
Scale bars, 100 μm. Error bars in A and C represent the mean±SE. *, P<0.05; **, P<0.01. 
dative stress-related parameters in vivo. We analyzed vas-
cular ROS production by quantification of dihydroethidine 
hydrochloride (DHE) staining. DHE-positive staining was 
rarely detected in the suprarenal aortic wall of saline- 
infused mice. AngII infusion markedly increased the level 
of ROS production in Apoe/ mice. However, densitometric 
analysis of DHE staining showed reduced staining in the 
suprarenal aortic wall of BAI-treated Apoe/ mice (Figure 
3A and B). Collectively, BAI ameliorates AngII-induced 
ROS in vivo. 
BAI treatment decreased AngII-induced vascular   
inflammation in vivo 
Vascular inflammation is implicated in AAA development, 
which is correlated with ROS production and MMP activa-
tion (Hellenthal et al., 2009b; Thompson et al., 2002). Few 
inflammatory cells were found in the suprarenal aortic wall 
of saline-infused mice. After AngII infusion, a large number 
of inflammatory cells, as determined by CD45 im-
munostaining, accumulated in the aortic wall especially in 
the adventitia of Apoe/ mice. However, the number of in-
flammatory cells was remarkably lower in the suprarenal 
aortic wall of AngII-infused Apoe/ mice after BAI treat-
ment (Figure 4A and B), than that after vehicle treatment. 
BAI treatment inhibited AngII-induced MMP-2 and 
MMP-9 activation to maintain elastin content in vivo 
Vascular smooth muscle cell (VSMC)-derived MMP-2 and 
macrophage-derived MMP-9 are considered as key factors 
in extracellular matrix degradation that is crucial for AAA 
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Figure 3  Baicalein (BAI) treatment inhibits angiotensin II (AngII)-induced reactive oxygen species (ROS) production in vivo. A, Representative DHE 
staining of suprarenal aortic wall of saline- and AngII-infused Apoe/ mice treated with vehicle or BAI (scale bars, 100 µm). B, Densitometric analysis of 
DHE staining of suprarenal aortic wall of saline- and AngII-infused Apoe/ mice treated with vehicle or BAI. n=6 per group. **, P<0.01; ***, P<0.001. The 
error bars in B are mean±SE. 
 
Figure 4  Baicalein (BAI) treatment inhibits angiotensin II (AngII)-induced vascular inflammation in vivo. A, Representative immunostaining with CD45 
of the suprarenal aortic wall of Apoe/ mice infused with saline or AngII following treatment with vehicle or BAI (scale bars, 100 µm). B, The number of 
CD45-positive cells accumulating in the suprarenal aortic wall of saline- (n=5 per group) and AngII-infused mice (n=7 per group) following treatment with 
vehicle or BAI. **, P<0.01; ***, P<0.001. Error bars in B represent the mean±SE. 
development and aortic rupture (Longo et al., 2002). First, 
we examined the activity of MMP-2 and MMP-9 in aorta 
homogenates by gelatin zymography. AngII infusion re-
markably induced MMP-2 activation (14.6-fold increase on 
an average) and MMP-9 activation (2.7-fold increase on an 
average) in Apoe/ mice; a lower degree of activation was 
observed in BAI-treated Apoe/ mice (MMP-2: 6.1-fold 
increase on an average; MMP-9: 1.9-fold increase on an 
average; Figure 5A–C). The expression of MMP-2 and 
MMP-9 markedly increased in AngII-infused Apoe/ mice. 
In contrast to the results obtained for vehicle groups, BAI 
treatment reduced MMP-2 and MMP-9 protein level after 
AngII treatment (Figure 5A, D and E).  
Next, medial elastin content was measured to detect ex-
tracellular matrix degradation. A marked decrease in aortic 
elastic fiber content was detected after AngII infusion for 4 
weeks relative to saline-infused mice. However, the elastin 
fiber content in the suprarenal aortas of BAI-treated mice 
after AngII infusion was significantly higher than that in 
vehicle-treated mice (Figure 6A and B). Taken together, 
these in vivo data suggest that AngII-induced MMP activa-
tion and extracellular matrix degradation are inhibited by 
BAI. 
BAI treatment blocked p38-mitogen activated protein 
kinase (MAPK) and JNK signaling pathways by down-
regulating AT1R in vivo 
The physiological and pathological effects of AngII are 
mainly mediated by its receptors, AT1R and AT2R (Mehta 
and Griendling, 2007). Thus, we examined whether 
BAI-treatment could influence the level of AngII receptors 
in mouse aorta. The data in Figure 7A–C shows that the 
protein level of AT1R was repressed after BAI treatment in 
the aortas of both saline- or AngII-infused Apoe/ mice. 
However, the AT2R expression was not affected by BAI 
administration. Next, we determined the downstream sig-
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Figure 5  Baicalein (BAI) treatment decreases angiotensin II (AngII)-induced matrix metalloproteinase (MMP)-2 and MMP-9 activation in vivo. A, Repre-
sentative gelatin zymography and western blots of MMP-2 and MMP-9 in vivo. B and C, Densitometric analysis of MMP-2 (B) and MMP-9 (C) activity in 
aorta homogenates. D and E, Densitometric analysis of MMP-2 (D) and MMP-9 (E) expression in aorta homogenates. Aorta homogenates were obtained 
from Apoe/ mice infused with saline or AngII for 4 weeks following treatment with vehicle or BAI. (n=8 in each group of Apoe/ mice infused with AngII; 
n=5 in each group of mice infused with saline). *, P<0.05; **, P<0.01; ***, P<0.001. Error bars in B–E represent the mean±SE. 
 
Figure 6  Baicalein (BAI) treatment ameliorates angiotensin II (AngII)-induced elastin degradation in vivo. A, Representative staining with elastin of su-
prarenal aortas from saline- and AngII-infused mice treated with vehicle or BAI. Scale bars, 100 μm. B, Quantitative analysis of elastin fiber content by 
quantification of the ratio of elastic fiber area to the suprarenal aortic media area in suprarenal aortas from saline and AngII-infused mice treated with vehicle 
or BAI. n=5 in each group of Apoe/ mice infused with saline. n=7 in the group of AngII-infused Apoe/ mice. ***, P<0.001. The error bars in B are 
mean±SE. 
naling cascades, MAPK activation, in the aortas of saline- 
or AngII-infused Apoe/ mice. After AngII infusion for 4 
weeks, p38-MAPK, Erk, and JNK signaling were upregu-
lated. In BAI-treated groups following AngII-infusion, 
p38-MAPK and JNK signaling but not Erk activation were 
attenuated, compared to vehicle-treated groups (Figure 
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Figure 7  Baicalein (BAI) reduces angiotensin type-1 receptor (AT1R) but not AT2R protein expression in vivo. A, Representative western blots of AT1R 
and AT2R in vivo. B and C, Densitometric analysis of AT1R (B) and AT2R (C) expression in aorta homogenates. The data of vehicle-treated mice infused 
with saline have been normalized as 1. Aorta homogenates were obtained from Apoe/ mice infused with saline or AngII for 4 weeks following treatment 
with vehicle or BAI. (n=7 in each group of Apoe/ mice infused with AngII; n=5 in each group of mice infused with saline). *, P<0.05; ***, P<0.001. NS 
represents no significance. Error bars in B and C represent the mean±SE. 
8A–D). In summary, BAI inhibits AngII cell signaling by 
downregulating AT1R in vivo. 
DISCUSSION 
In this study, we showed for the first time that BAI protects 
against AngII-induced AAA in Apoe/ mice. BAI treatment 
significantly reduces AAA incidence and aorta dilatation in 
vivo. Mechanically, it attenuates AngII-induced oxidative 
stress, vascular inflammation, and extracellular matrix deg-
radation. Moreover, it inhibits JNK and p38-MAPK signal-
ing by AT1R downregulation (summarized in Figure 9). 
Our findings suggest a new agent for AAA pharmacothera-
py. 
Currently, there is no effective pharmacological therapy 
to prevent or suppress AAA development and progression. 
Intraperitoneal injection of BAI (30 mg kg1 day1) mark-
edly reduced the incidence of AAA in AngII-infused Ap-
oe/ mice. More importantly, the severity of AAA (the ratio 
of aorta weight to body weight and maximal abdominal 
aortic diameter) decreased in response to BAI treatment in 
AngII-infused mice, suggesting that BAI protects against 
not only AAA initiation but also its progression.  
Augmented oxidative stress plays a vital role in AAA 
development (Keaney, 2005; Zhang et al., 2003). In the 
present study, we found that ROS production as examined 
by DHE staining was inhibited in mouse aortas after BAI 
treatment. The mechanisms underlying the antioxidant ef-
fect of BAI mainly include ROS scavenging and decreased 
ROS production (Gao et al., 1999; Kang et al., 2012;  
Shao et al., 1999). Moreover, oxidative stress is closely  
associated with inflammation and MMP activation 
(Hellenthal et al., 2009a, b). For example, the expression of 
monocyte chemotactic protein 1 (MCP-1) and MMP-2 is 
partly regulated by some redox-sensitive transcriptional 
factors such as nuclear factor (NF)-B (Finkel and 
Holbrook, 2000). Thus, decreased ROS production leads to 
the inhibition of subsequent inflammation and extracellular 
matrix degradation. As shown in our figures, inflammatory 
cell accumulation in aortic wall is attenuated by BAI treat-
ment. According to our data, inflammatory cells are mainly 
localized in vascular adventitia, indicating that the cells may 
be from the blood circulation. Previous reported data show 
that the majority of ROS is secreted by inflammatory cells 
such as monocytes and macrophages (Thompson et al., 
2002). Thus, BAI-induced attenuation of inflammation also 
results in decreased ROS production. During AAA devel-
opment, the vascular wall stress increases following extra 
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Figure 8  Baicalein (BAI) inhibits p38-mitogen activated protein kinase (MAPK) and JNK but not Erk activation in vivo. A, Representative western blots 
of p38-MAPK, Erk, and JNK in vivo. B–D, Densitometric analysis of p38-MAPK (B), Erk (C), and JNK (D) expression in aorta homogenates. The data of 
vehicle-treated mice infused with saline have been normalized as 1. Aorta homogenates were obtained from Apoe/ mice infused with saline or AngII for 4 
weeks following treatment with vehicle or BAI. (n=7 in each group of Apoe/ mice infused with AngII; n=5 in each group of mice infused with saline). *, 
P<0.05; ***, P<0.001. NS represents no significance. Error bars in B–D represent the mean±SE. 
 
Figure 9 (color online)  Baicalein (BAI) plays a critical role in angioten-
sin II (AngII) cascade inhibition. AngII binds to its receptor angiotensin 
type-1 receptor (AT1R) to activate mitogen activated protein kinases 
(MAPKs) and to induce reactive oxygen species (ROS) production, which 
further increases vascular inflammation and ECM degradation. BAI atten-
uates AngII-induced oxidative stress, vascular inflammation, and extracel-
lular matrix degradation in vivo. Mechanically, BAI inhibits JNK and 
p38-MAPK signaling by AT1R downregulation. 
cellular matrix degradation, which leads to the final aortic 
rupture (Vorp, 2007). VSMC-derived MMP-2 and macro-
phage-derived MMP-9 are of great importance in the  
process of ECM degradation (Galis and Khatri, 2002; 
Longo et al., 2002). Our data show that both the expression 
and the activity of MMP-2 and MMP-9 are inhibited by 
BAI treatment, indicating that the main target of BAI may 
be VSMCs and macrophages. These effects of BAI result in 
the preservation of the wavy structure of the elastic lamellae 
and the elastic content to prevent AAA development and 
aortic rupture. 
The majority of the known effects of AngII are mediated 
by AT1Rs, which are widely distributed in the lung, kidney, 
and heart. While the majority of the vasoactive effects of 
AngII occur via AT1Rs, AT2Rs have been shown to have 
anti-proliferative and pro-apoptotic effects in VSMCs, 
mainly by antagonizing AT1Rs (Griendling et al., 1996). 
Our data show that in saline- and AngII-infused aortas, 
AT1R but not AT2R is downregulated with BAI treatment, 
resulting in AngII cascade blockade. For the downstream 
signaling pathways, we examined MAPK activation in vivo,  
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which is implicated in cellular protein synthesis, gene ex-
pression, metabolism, and growth. Interestingly, JNK and 
p38-MAPK but not Erk pathways were downregulated fol-
lowing BAI treatment. It has been reported that inhibition of 
JNK pathway prevents AAA development through MMP-2 
and MMP-9 suppression (Yoshimura et al., 2005). Our re-
sults and previous data indicate that MAPK signaling path-
ways could be considered novel therapeutic targets of AAA 
treatment. 
In conclusion, BAI treatment in Apoe/ mice inhibits 
AAA formation induced by AngII infusion and is associated 
with a reduction of oxidative stress, vascular inflammation, 
and ECM degradation. The effects of BAI are mediated by 
the inhibition of JNK and p38-MAPK pathways through 
AT1R downregulation. Our findings represent novel thera-
peutic agent particularly for prevention of AAA initiation 
and progression. 
MATERIALS AND METHODS  
Generation of mice 
All the animal protocols were approved by the Animal Care 
and Use Committee at the Institute of Basic Medical Sci-
ences, Chinese Academy of Medical Sciences & Peking 
Union Medical College (CAMS&PUMC). The Apoe/ and 
C57BL/6J mice were obtained from Peking University 
(Beijing). 
Blood pressure and serum lipid measurements 
Heart rate (HR) and systolic blood pressure (SBP) of the 
animals were measured using tail-cuff plethysmography 
(BP-2000 System, Visitech Systems, Apex, USA) as de-
scribed previously (Li et al., 2011). Blood samples were 
obtained from the mice before sacrifice. The blood was col-
lected from the abdominal vena cava at sacrifice. Serum 
cholesterol, triglyceride, high-density lipoprotein-     
cholesterol (HDL-C), and low-density lipoprotein-     
cholesterol (LDL-C) were measured at the clinical labora-
tory of Peking Union Medical College Hospital. 
Analyses and quantification of AAA 
Four- to 6-month-old male mice fed a normal chow diet 
were used. All the mice were infused with AngII (Sig-
ma-Aldrich, A9525, USA) at 1.44 mg kg1 day1 or saline 
for 4 weeks by using Alzet osmotic pumps (model 2004, 
DURECT Corp., USA). The experiments were performed as 
previously described (Satoh et al., 2009). An aortic aneu-
rysm is defined as the increase in the external width of the 
suprarenal aorta by 50% or greater compared with that in 
saline-infused mice. The maximum width of the abdominal 
aorta was analyzed with Image Pro Plus software (Media 
Cybernetics). 
BAI treatment 
One week before AngII or saline infusion, mice were 
pre-treated with BAI (Sigma-Aldrich, 465119, USA) dis-
solved in propylene glycol (vehicle). BAI was administered 
through intraperitoneal injection at two tentative dosages: 
30 and 100 mg kg1 day1. Majority of the mice in the 100 
mg kg1 day1 group died of peritoneal inflammation within 
1 week after BAI treatment. In contrast, all the mice in the 
30 mg kg1 day1 group were in good condition during BAI 
treatment. Therefore, we selected 30 mg kg1 day1 dose for 
subsequent experiments. During AngII or saline infusion, 
experimental mice were also treated with the same dosage 
of BAI at the same time-point daily. 
Histological analyses 
After hemodynamic measurements, the animals were sacri-
ficed. For morphological analysis, the aortas were perfused 
with normal saline and fixed with 10% phosphate buffer 
saline (PBS) and formalin at physiological pressure for 5 
min. The whole aortas were harvested, fixed for 24 h, em-
bedded in paraffin, and cross-sections (5 µm) were pre-
pared. Paraffin sections were stained with elastin van Gie-
son, H&E, or used for immunostaining. 
Immunohistochemistry 
Slides were deparaffinized, and endogenous peroxidase 
activity was quenched with 3% (v/v) hydrogen peroxide in 
10% PBS for 10 min. Nonspecific binding sites were 
blocked with 10% bovine serum in PBS at room tempera-
ture for 1 h. Slides were incubated at 4°C overnight with 
diluted primary antibodies, then with biotinylated secondary 
antibody at 37°C for 30 min, and subsequently with horse-
radish peroxidase-labeled streptavidin solution for 20 min at 
37°C. Slides were then stained with diaminobenzidine and 
counterstained with hematoxylin. The primary antibody 
used was CD45 (clone Ly-5, 1:100 dilution; BD 
Pharmingen, USA). A mean value was determined from at 
least 4 sections in each animal. 
Western blot analyses 
Western blots were performed as described previously 
(Zhou et al., 2011). The primary antibodies used were 
mouse MMP-2 (sc-13595, 1:1000 dilution; SANTA CRUZ, 
USA), mouse GAPDH (5174, 1:3000 dilution; Cell Signal-
ing Technology, USA), mouse MMP-9 (G657, 1:1000 dilu-
tion; Cell Signaling Technology, USA), mouse AT1R 
(sc-579, 1:2000 dilution; SANTA CRUZ, USA), mouse 
AT2R (sc-9040, 1:2000 dilution; SANTA CRUZ, USA), 
p38-MAPK (9212, 1:2000 dilution; Cell Signaling Tech-
nology, USA), phospho-p38-MAPK (9211, 1:2000 dilu-
tion; Cell Signaling Technology, USA), Erk1/2 (9102, 
1:2000 dilution; Cell Signaling Technology, USA), phos-
pho-Erk1/2 (9101, 1:2000 dilution; Cell Signaling Tech-
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nology, USA), JNK (9252, 1:2000 dilution; Cell Signaling 
Technology, USA), and phospho-JNK (9251, 1:2000 dilu-
tion; Cell Signaling Technology, USA). Western blots were 
quantified densitometrically with Quantity One software 
(Bio-Rad), and the intensity values were normalized to 
GAPDH. 
Matrix metalloproteinase (MMP) activity 
The detection of MMP-2 and MMP-9 activity was per-
formed as previously reported (Hawkes et al., 2010). Five 
micrograms of protein in the concentrated aortic homoge-
nates was electrophoresed on SDS-PAGE gels containing 
gelatin. Gels were washed in 2.5% Triton X-100 for 30 min 
and incubated for 12–40 h with zymography development 
buffer at 37°C. Subsequently, the gel was stained with 
Coomassie brilliant blue. 
ROS analysis 
The aortic tissue was harvested, and the suprarenal ab-
dominal  aorta were embedded in OCT (C1400, 
APPLYGEN, Beijing) and snap-frozen. DHE (5 µmol L1, 
D-23107, Molecular Probes, USA) was topically applied to 
the freshly cut, frozen aortic sections (10 µm) for 30 min at 
37°C to detect the presence of ROS as red fluorescence  
(585 nm) by confocal microscopy (Olympus). 
Statistical analyses 
Quantitative results are expressed as the mean±SE. Fisher’s 
exact test was applied to the comparisons of AAA incidence 
and mortality. Comparisons of parameters between two 
groups were performed using the unpaired Student t-test or 
a nonparametric test. Comparisons of parameters between 
more than two groups were performed by one-way 
ANOVA, and comparisons of different parameters between 
each group were made by a post hoc analysis using the 
Bonferroni test. Statistical significance was evaluated with 
GraphPad Prism 5. A P value less than 0.05 was considered 
statistically significant. 
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